About Us
Overview
The mission of Epigenovix Diagnostics is to eradicate chronic diseases, particularly cancer and the suffering they causes through education in lifestyle modifications and laboratory testing to help detect disease earlier and guide treatment. From education to early disease detection, we are helping people to know their disease risk and face the most challenging diseases with confidence.
We are leaders in education- cancer prevention; factors that drives health disparities and the role of gene-environment interactions associated chronic diseases.
Disease detection- we use a panel of DNA methylation markers and other genetic tests in different types of biospecimen (saliva, urine, blood, and tissues) for disease screening.
Our team is dedicated to exploring sensitive and specific biological markers for disease detection. We build on a core set of values: innovation, integrity, quality, teamwork, and accountability.
We at Epigenovix Diagnostics are changing lives through education and early disease detection.
Our leader: Dr. Bernard Kwabi-Addo, PhD
Dr. Bernard Kwabi-Addo, PhD is the founder and Chief Executive Officer of Epigenovix Diagnostics. He leads Epigenovix in the design and development of genetic and epigenetic biomarkers for disease detection. Dr. Kwabi-Addo is a cancer biologist and a Principal Investigator of a prostate cancer research laboratory at Howard University in Washington D.C. and an Adjunct faculty member at Johns’ Hopkins Medical School in Baltimore, Maryland.
Dr. Kwabi-Addo is active in the DMV (Washington D.C., Maryland, and Virginia) communities. He serves as a healthcare educator on cancer topics, health disparities and factors driving chronic diseases.
Dr. Kwabi-Addo carried out his postdoctoral training at Baylor College of Medicine in Houston TEXAS where his work focused on the role of Receptor Tyrosine Kinase signaling and genetic alterations of PTEN tumor suppressor in prostate carcinogenesis.
Dr. Kwabi-Addo holds a BSc. Degree in Biochemistry from University of Dundee (Scotland), and a MSc. Degree in Molecular Biology and Biotechnology from University College London. We worked at the Medical Research laboratories at the Addenbrookes Hospital in Cambridge (UK) as a research scientist and subsequently earned a PhD degree in Molecular Biology from the University of London (Queen Mary and Westfield) on a collaborative scholarship program with Glaxo-SmithKline in Stevenage, United Kingdom.
Dr. Kwabi-Addo has written many scientific publications in top peer-review journals. He has received several scientific awards, including the Minority-Serving Institution Faculty Scholar Award given by the American Association for Cancer Research. Dr. Kwabi-Addo, is the author of 3 books: 1. Cancer Causes and Controversies- Understanding Risk Reduction and Prevention (Praeger, 2011). 2. Health Outcome in a Foreign Land- Gene-Environment Interaction (Springer June 2017). 3. Check The FATS! (Under review, Elite Publishers, 2021).
